Dana Investment Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,638
| Closed | -$118K | – | 556 |
|
|
2025
Q1 | $118K | Buy |
17,638
+30
| +0.2% | +$200 | ﹤0.01% | 537 |
|
|
2024
Q4 | $221K | Buy |
17,608
+2,627
| +18% | +$33K | 0.01% | 527 |
|
|
2024
Q3 | $277K | Buy |
14,981
+1,134
| +8% | +$20.9K | 0.01% | 500 |
|
|
2024
Q2 | $298K | Buy |
13,847
+586
| +4% | +$12.6K | 0.01% | 482 |
|
|
2024
Q1 | $357K | Sell |
13,261
-156
| -1% | -$4.2K | 0.01% | 470 |
|
|
2023
Q4 | $402K | Sell |
13,417
-1,992
| -13% | -$59.7K | 0.02% | 343 |
|
|
2023
Q3 | $316K | Sell |
15,409
-1,315
| -8% | -$26.9K | 0.02% | 357 |
|
|
2023
Q2 | $332K | Buy |
16,724
+931
| +6% | +$18.5K | 0.02% | 355 |
|
|
2023
Q1 | $271K | Buy |
15,793
+1,420
| +10% | +$24.3K | 0.01% | 363 |
|
|
2022
Q4 | $281K | Buy |
+14,373
| New | +$281K | 0.01% | 368 |
|